Logo Logo
Hilfe
Hilfe
Switch Language to English

Chaloupka, M.; Westhofen, T.; Kretschmer, A.; Grimm, T.; Stief, C. und Apfelbeck, M. (2019): Active Surveillance beim Prostatakarzinom. Ein Update. In: Urologe, Bd. 58, Nr. 3: S. 329-340

Volltext auf 'Open Access LMU' nicht verfügbar.

Abstract

Prostate cancer is aheterogeneous disease. In cases of low-risk prostate cancer, active surveillance represents an attractive alternative treatment. Significant complications of a definitive treatment can therefore be delayed or completely avoided. Despite strict inclusion criteria for active surveillance, the diagnosis of low-risk prostate cancer can be inaccurate and there is therefore arisk of missing the optimal point in time for definitive treatment. Multimodal diagnostics and continuous aftercare are therefore crucial.

Dokument bearbeiten Dokument bearbeiten